Danielle Rodin

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Early Breast Cancer

Cross Sectional

Top Venues

JCO global oncology

Current oncology (Toronto, Ont.)

JCO oncology practice

Journal of medical Internet research

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew Beckett, Mustafa Al Balushi, Jessica Chan, Victor Iakovenko, Michael Roumeliotis, Timothy P Hanna, Fleur Huang, Maroie Barkati, Danielle Rodin, Jean-Marc Bourque
Pan-Canadian Survey of Radiation Oncology Professional Involvement in Global Oncology Initiatives in Low- and Middle-Income Countries. JCO global oncology 10 (2024)
Matthew Beckett, Mustafa Al Balushi, Jessica Chan, Victor Iakovenko, Michael Roumeliotis, Timothy P Hanna, Fleur Huang, Maroie Barkati, Danielle Rodin, Jean-Marc Bourque
Pan-Canadian Survey of Radiation Oncology Professional Involvement in Global Oncology Initiatives in Low- and Middle-Income Countries. JCO global oncology 10 (2024)
Ezra Hahn, Rinku Sutradhar, Lawrence Paszat, Lena Nguyen, Danielle Rodin, Sharon Nofech-Mozes, Sabina Trebinjac, Katarzyna Joanna Jerzak, Cindy Fong, Eileen Rakovitch
Molecular Expression Assays Improve the Prediction of Local and Invasive Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew Beckett, Mustafa Al Balushi, Jessica Chan, Victor Iakovenko, Michael Roumeliotis, Timothy P Hanna, Fleur Huang, Maroie Barkati, Danielle Rodin, Jean-Marc Bourque
Pan-Canadian Survey of Radiation Oncology Professional Involvement in Global Oncology Initiatives in Low- and Middle-Income Countries. JCO global oncology 10 (2024)
Matthew Beckett, Mustafa Al Balushi, Jessica Chan, Victor Iakovenko, Michael Roumeliotis, Timothy P Hanna, Fleur Huang, Maroie Barkati, Danielle Rodin, Jean-Marc Bourque
Pan-Canadian Survey of Radiation Oncology Professional Involvement in Global Oncology Initiatives in Low- and Middle-Income Countries. JCO global oncology 10 (2024)
Melinda Mushonga, Jessica Weiss, Zhihui Amy Liu, Anna-Mary Nyakabau, Osama Mohamad, Bouchra Tawk, Fabio Ynoe de Moraes, Surbhi Grover, Mei Ling Yap, Eduardo Zubizarreta, Yolande Lievens, Danielle Rodin
Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey. JCO global oncology 9 (2023)
Ezra Hahn, Danielle Rodin, Rinku Sutradhar, Sharon Nofech-Mozes, Sabina Trebinjac, Lawrence Frank Paszat, Eileen Rakovitch
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS? Current oncology (Toronto, Ont.) 30 (6) (2023)
Leslie E Oldfield, Vivien Jones, Bhajan Gill, Nardeen Kodous, Rouhi Fazelzad, Danielle Rodin, Harminder Sandhu, Ben Umakanthan, Janet K Papadakos, Meredith Elana Giuliani
Synthesis of Existent Oncology Curricula for Primary Care Providers: A Scoping Review With a Global Equity Lens. JCO global oncology 9 (2023)
Ezra Hahn, Danielle Rodin, Rinku Sutradhar, Sharon Nofech-Mozes, Sabina Trebinjac, Lawrence Frank Paszat, Eileen Rakovitch
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS? Current oncology (Toronto, Ont.) 30 (6) (2023)
Ezra Hahn, Danielle Rodin, Rinku Sutradhar, Sharon Nofech-Mozes, Sabina Trebinjac, Lawrence Frank Paszat, Eileen Rakovitch
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS? Current oncology (Toronto, Ont.) 30 (6) (2023)
Leslie E Oldfield, Vivien Jones, Bhajan Gill, Nardeen Kodous, Rouhi Fazelzad, Danielle Rodin, Harminder Sandhu, Ben Umakanthan, Janet K Papadakos, Meredith Elana Giuliani
Synthesis of Existent Oncology Curricula for Primary Care Providers: A Scoping Review With a Global Equity Lens. JCO global oncology 9 (2023)
Adam Suleman, Abi Vijenthira, Zhihui Amy Liu, Tran Truong, Alejandro Berlin, Anca Prica, Danielle Rodin
Virtual Care During the COVID-19 Pandemic for Patients With Hematologic Malignancies: A Single-Institution Experience. JCO oncology practice (2023)
Ezra Hahn, Danielle Rodin, Rinku Sutradhar, Sharon Nofech-Mozes, Sabina Trebinjac, Lawrence Frank Paszat, Eileen Rakovitch
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS? Current oncology (Toronto, Ont.) 30 (6) (2023)
Melinda Mushonga, Jessica Weiss, Zhihui Amy Liu, Anna-Mary Nyakabau, Osama Mohamad, Bouchra Tawk, Fabio Ynoe de Moraes, Surbhi Grover, Mei Ling Yap, Eduardo Zubizarreta, Yolande Lievens, Danielle Rodin
Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey. JCO global oncology 9 (2023)
Melinda Mushonga, Jessica Weiss, Zhihui Amy Liu, Anna-Mary Nyakabau, Osama Mohamad, Bouchra Tawk, Fabio Ynoe de Moraes, Surbhi Grover, Mei Ling Yap, Eduardo Zubizarreta, Yolande Lievens, Danielle Rodin
Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey. JCO global oncology 9 (2023)
Ali Sabbagh, Jessica Weiss, Bouchra Tawk, Mohammed A Mohammed, Hasan Abdulbaki, Fabio Ynoe de Moraes, Surbhi Grover, Mei Ling Yap, Eduardo Zubizarreta, Yolande Lievens, Danielle Rodin, Osama Mohamad
Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey. JCO global oncology 9 (2023)
Danielle Rodin, Rinku Sutradhar, Sharon Nofech-Mozes, Sumei Gu, Neil Faught, Ezra Hahn, Cindy Fong, Sabina Trebinjac, Lawrence Paszat, Eileen Rakovitch
Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy. Breast cancer research and treatment 192 (1) (2022)
Amir H Safavi, Mike Lovas, Zhihui Amy Liu, Sheena Melwani, Tran Truong, Shayla Devonish, Nazek Abdelmutti, Ambreen Sayani, Danielle Rodin, Alejandro Berlin
Virtual Care and Electronic Patient Communication During COVID-19: Cross-sectional Study of Inequities Across a Canadian Tertiary Cancer Center. Journal of medical Internet research 24 (11) (2022)
Danielle Rodin, Alyna T Chien, Chad Ellimoottil, Paul L Nguyen, Pragya Kakani, Matthew Mossanen, Meredith Rosenthal, Mary Beth Landrum, Anna D Sinaiko
Physician and facility drivers of spending variation in locoregional prostate cancer. Cancer 126 (8) (2020)